Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia
Summary by The Daily Star
An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely-watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday.
Published 4 months ago · S F, United States
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)